Me Today (NZSE:MEE) Research & Development: NZ$0.00 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NZSE:MEE Me Today Ltd NZSE:MEE
22 GF Score
Price NZ$0.14
GF Value NZ$0.05
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Me Today Research & Development?

Me Today NZSE:MEE +19.66% 22 Research & Development is NZ$0.00 Mil as of Dec. 2025. GuruFocus rates NZSE:MEE with a GF Score™ of 22/100 and a GF Value™ of NZ$0.05 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Me Today's Research & Development for the six months ended in Dec. 2025 was NZ$0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was NZ$0.00 Mil.

Me Today  (NZSE:MEE) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Me Today Research & Development Related Terms

Me Today Research & Development Historical Data

* Premium members only.

The historical data trend for Me Today's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Me Today Research & Development Chart

Me Today Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Mar20 Mar21 Jun23 Jun24 Jun25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Me Today Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Mar20 Sep20 Mar21 Sep21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NZSE:MEE
22GF Score
Me Today Ltd NZSE:MEE
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Me Today Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was NZ$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of NZ$0.00 Mil mean?
Me Today (NZSE:MEE) has a Research & Development of NZ$0.00 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Me Today and its competitors.
Is Me Today's Research & Development too high?
Me Today's current Research & Development is NZ$0.00 Mil. Overall, Me Today has a GF Score™ of 22/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Me Today's Research & Development compare to KHC and GIS?
Me Today's Research & Development of NZ$0.00 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Consumer Packaged Goods company?
A good Research & Development depends on the Consumer Packaged Goods industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Me Today and its competitors. Me Today's current Research & Development is NZ$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Me Today stock overvalued right now?
Based on GuruFocus' analysis, Me Today (NZSE:MEE) is currently considered Significantly Overvalued. The stock's GF Value™ is NZ$0.05, compared to a current price of NZ$0.14 — trading 180% above its estimated fair value. The current Research & Development is NZ$0.00 Mil. Me Today's overall GF Score™ is 22/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Me Today (NZSE:MEE), the current Research & Development is NZ$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Me Today (NZSE:MEE) Overvalued in 2026?

Based on GuruFocus' analysis, Me Today stock appears to be overvalued. The current stock price of NZ$0.14 is trading 180% above its estimated GF Value™ of NZ$0.05. GuruFocus considers Me Today to be Significantly Overvalued.

Key valuation signals for NZSE:MEE:

  • Research & Development: NZ$0.00 Mil
  • GF Value™: NZ$0.05 vs. price of NZ$0.14 (180% above fair value)
  • GF Score™: 22/100 with 7 warning signs

No single metric tells the full story. See the NZSE:MEE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Me Today Business Description

Address 25 Broadway, Level 1, Newmarket, Auckland, NZL, 1141
Me Today Ltd is engaged in providing general health supplements and skincare products. It produces, sells, and markets health and well-being products or acts as an agent on behalf of other health and well-being suppliers. The company also produces and distributes premium manuka honey. Some of the products offered by the company are sleep supplements, immunity supplements, multivitamin skincare, skincare serums, lozenges, and others. Its operating segments are the Me Today brand, King Honey, and Agency services. Maximum revenue is generated from its Me Today brand segment, which produces premium manuka honey. Geographically, the company generates maximum revenue from New Zealand and the rest from Europe and the United States of America.
22GF Score

Get the complete analysis for NZSE:MEE

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NZ$0.14
Price
NZ$0.05
GF Value